Phytoestrogen resveratrol suppresses steroidogenesis by rat adrenocortical cells by inhibiting cytochrome P450 c21-hydroxylase

Hormone Research

Volumn 64, Issue 6, 2005, Pages 280-286

  Supornsilchai, V ^a   Svechnikov, K ^a   Seidlova Wuttke, D ^b   Wuttke, W ^b   Soder O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adrenocortical steroidogenesis; Corticosterone; Cytochrome P450 c21 hydroxylase; Progesterone; Resveratrol

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; PHYTOESTROGEN; PROGESTERONE; RESVERATROL; STEROID 21 MONOOXYGENASE;

ADRENAL CORTEX CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; EX VIVO STUDY; HORMONE SYNTHESIS; IN VITRO STUDY; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; STEROIDOGENESIS; WESTERN BLOTTING;

EID: 28744432058     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089487     Document Type: Article

References (26)

1. Fisher JS: Environmental anti-androgens and male reproductive health: Focus on phthalates and testicular dysgenesis syndrome. Reproduction 2004;127:305-315.
2. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS: Resveratrol-associated renal toxicity. Toxicol Sci 2004;82:614-619.
3. Mesiano S, Katz SL, Lee JY, Jaffe RB: Phytoestrogens alter adrenocortical function: Genistein and daidzein suppress glucocorticoid and stimulate androgen production by cultured adrenal cortical cells. J Clin Endocrinol Metab 1999;84:2443-2448.
4. Li W, Seifert M, Xu Y, Hock B: Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays. Environ Int 2004;30:329-335.
5. Siemann EH, Creasy LL: Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992;43:49-52.
6. Gehm BD, McAndrews JM, Chien PY, Jameson JR: Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997;94:14138-14143.
7. Di S, Zhang Z, Wang Y, Shi W: Analysis for four isomers of resveratrol in red wine by high performance liquid chromatography. Se Pu 2004;22:424-427.
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:21820.
9. Alarcón C, Villegas I: Review: Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol Nutr Food Res 2005;49:405-430.
10. Frankel EN, Waterhouse AL, Kinsella JE: Inhibition of human LDL oxidation by resveratrol. Lancet 1993;341:1103-1104.
11. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, Bertelli A: Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tiss React 1995;17:1-3.
12. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM: The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;235:207-219.
13. Goldberg DM, Hahn SE, Parkes JG: Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 1995;237:155-187.
14. Marier J-F, Vachon P, Gritsas A, Zhang J, Morean J-P, Ducharme MP: Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002;302:369-373.
15. Preziosi P: Natural and anthropogenic environmental oestrogens: the scientific basis for risk assessment. Endocrine disrupters as environmental signalers: an introduction. Pure Appl Chem 1998;70:1617-1631.
16. Ohno S, Nakajima Y, Inoue K, Nakazawa H, Nakajin S: Genistein administration decreases serum corticosterone and testosterone levels in rats. Life Sci 2003;74:733-742.
17. Kristan K, Krajnc K, Konc J, Gobec S, Stojan J, Rizner TL: Phytoestrogens as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase. Steroids 2005;70:694-703.
18. Frémont L: Minireview: Biological effects of resveratrol. Life Sci 2000;66:663-673.
19. Kowalski J, Samojedny A, Paul M, Pietsz G, Wilczok T: Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep 2005;57:390-394.
20. Gell JS, Oh J, Rainey WE, Carr BR: Effect of estradiol on DHEAS production in the human adrenocortical cell line, H295R. J Soc Gynecol Invest 1998;5:144-148.
21. Mesiano S, Jaffe RB: Interaction of insulin-like growth factor-II and estradiol directs steroidogenesis in the human fetal adrenal toward dehydroepiandrosterone sulfate production. J Clin Endocrinol Metab 1993;77:754-758.
22. Osborne CK, Zhao H, Fuqua SAW: Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 2000;18:3172-3186.
23. Akingbemi BT, Ge R, Rosenfeld CS, Newton LG, Hardy DO, Catterall JF, Lubahn DB, Korach KS, Hardy MP: Estrogen receptor-alpha gene deficiency enhances androgen biosynthesis in the mouse Leydig cell. Endocrinology 2003;144:84-93.
24. Culpitt SV, Rogers DF, Fenwick PS, Shah P, De Matos C, Russell RE, Barnes PJ, Donnelly LE: Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 2003;58:942-946.
25. Tominaga T, Fukata J, Naito Y, Usui T, Murakami N, Fukushima M, Nakai Y, Hirai Y, Imura H: Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology 1991;128:526-531.
26. Path G, Scherbaum WA, Bornstein SR: The role of interleukin-6 in the human adrenal gland. Eur J Clin Invest 2000;30(suppl 3):91-95.